$schema: "http://json-schema.org/draft-04/schema#"

id: "study"
title: Study
type: object
namespace: https://nci-crdc-demo.datacommons.io/
category: administrative
program: '*'
project: '*'
description: >-
  A coordinated set of actions and observations designed to generate data, with the
  ultimate goal of discovery or hypothesis testing.
additionalProperties: false
submittable: true

systemProperties:
  - id
  - project_id
  - state
  - created_datetime
  - updated_datetime

links:
  - name: projects
    backref: studies
    label: performed_for
    target_type: project
    multiplicity: many_to_one
    required: true

required:
  - submitter_id
  - type
  - projects

uniqueKeys:
  - [id]
  - [project_id, submitter_id]

properties:

  $ref: "_definitions.yaml#/ubiquitous_properties"

  imp_me_studyname:
    description: >-
      Which study is the patient participating in?
    enum: []

  imp_bstrong_pop:
    description: >-
      Population: Opioid use disorder and low back pain
    type: number

  imp_bstrong_inter:
    description: >-
      Intervention: Yoga vs Physical Therapy vs Treatment as usual (TAU)
    type: number

  imp_bstrong_sd:
    description: >-
      Study Design: 3 Arm RCT; Type I
    type: number

  imp_bstrong_if:
    description: >-
      Implementation Framework: RE-AIM & CFIR
    type: number

  imp_bstrong_econ:
    description: >-
      Economic analysis: Yes
    type: number

  imp_bstrong_moud:
    description: >-
      MOUD: Methadone
    type: number

  imp_bstrong_setting:
    description: >-
      Health Setting: Methadone Clinic
    type: number

  imp_bstrong_sample:
    description: >-
      Sample size: 345
    type: number

  imp_bstrong_followup:
    description: >-
      Follow-up: 1, 2, 3, 6, 9 months
    type: number

  impowr_ime2_pop:
    description: >-
      Population: OUD and nonspecific pain
    type: number

  impowr_ime2_inter:
    description: >-
      Intervention: ACT vs care management vs ACT + care management vs Treatment as
      usual (TAU)
    type: number

  impowr_ime2_sd:
    description: >-
      Study Design: 2x2 Factorial Design; Type I
    type: number

  impowr_ime2_if:
    description: >-
      Implementation Framework: RE-AIM & CFIR
    type: number

  impowr_ime2_econ:
    description: >-
      Economic analysis: yes
    type: number

  impowr_ime2_moud:
    description: >-
      MOUD: Buprenorphine
    type: number

  impowr_ime2_setting:
    description: >-
      Health Setting: Primary Care (FQHCs)
    type: number

  impowr_ime2_sample:
    description: >-
      Sample size: 980
    type: number

  impowr_ime2_followup:
    description: >-
      Follow ups: 0, 1.5, 3, 6, 9 months
    type: number

  imp_bup_pop:
    description: >-
      Population: OUD and nonspecific chronic pain
    type: number

  imp_bup_inter:
    description: >-
      Intervention: Buprenorphine standard induction vs microdosing
    type: number

  imp_bup_sd:
    description: >-
      Study Design: 2 Arm RCT; Type I
    type: number

  imp_bup_if:
    description: >-
      Implementation framework: RE-AIM & CFIR
    type: number

  imp_bup_econ:
    description: >-
      Economic Analysis: yes
    type: number

  imp_bup_moud:
    description: >-
      MOUD: Buprenorphine
    type: number

  imp_bup_setting:
    description: >-
      Health Setting: Hospitals
    type: number

  imp_bup_sample:
    description: >-
      Sample size: 270
    type: number

  imp_bup_followup:
    description: >-
      Follow-up: 0, 0.25, 1, 3, 6 months
    type: number

  imp_you_studyname:
    description: >-
      Which study is the patient participating in?
    enum: []

  imp_champ_pop:
    description: >-
      Population: OUD/misuse; nonspecific CP
    type: number

  imp_champ_inter:
    description: >-
      Intervention: Pharmacist + physician tele-consulting (TCM) vs TCM + CBT (COPES)
    type: number

  imp_champ_sd:
    description: >-
      Study design: 2 Arm RCT; Type II
    type: number

  imp_champ_if:
    description: >-
      Implementation Framework: i-PARIHS
    type: number

  imp_champ_econ:
    description: >-
      Economic analysis: Yes
    type: number

  imp_champ_moud:
    description: >-
      MOUD: Buprenorphine
    type: number

  imp_champ_setting:
    description: >-
      Setting: Primary Care
    type: number

  imp_champ_sample:
    description: >-
      Sample size: 1600
    type: number

  imp_champ_followup:
    description: >-
      Follow-up: 12 months
    type: number

  imp_scpowr_pop:
    description: >-
      Population: OUD; nonspecific CP
    type: number

  imp_scpowr_inter:
    description: >-
      Intervention: Multimodal stepped care interdisciplinary (CBT ðŸ¡ª exercise ðŸ¡ª stress
      mgmt) vs TAU
    type: number

  imp_scpowr_sd:
    description: >-
      Study design: Stage II Stepped Care
    type: number

  imp_scpowr_if:
    description: >-
      Implementation framework: N/A
    type: number

  imp_scpowr_econ:
    description: >-
      Economic analysisL Yes, as exploratory aim
    type: number

  imp_scpowr_moud:
    description: >-
      MOUD: Methadone & Buprenorphine
    type: number

  imp_scpowr_setting:
    description: >-
      Health Setting: OTP
    type: number

  imp_scpowr_sample:
    description: >-
      Study size: 328
    type: number

  imp_scpowr_follow:
    description: >-
      Follow-up: 6, 9, 12 months
    type: number

  imp_tree_studyname:
    description: >-
      Which study is the patient participating in?
    enum: []

  imp_eng_pop:
    description: >-
      Population: OUD; nonspecific CP
    type: number

  imp_eng_inter:
    description: >-
      Intervention: PSM + MOUD vs Enhanced Treatment as usual
    type: number

  imp_eng_sd:
    description: >-
      Study design: 2 Arm RCT; Hybrid Type I
    type: number

  imp_eng_moud:
    description: >-
      MOUD: Buprenorphine/naloxone
    type: number

  imp_eng_if:
    description: >-
      Implementation framework: Health Equity Implementation Framework
    type: number

  imp_eng_econ:
    description: >-
      Economic analysis: yes
    type: number

  imp_eng_setting:
    description: >-
      Health setting: primary care
    type: number

  imp_eng_sample:
    description: >-
      Sample size: 378
    type: number

  imp_eng_followup:
    description: >-
      Follow-up: 0, 1, 2, 3, 6, 12 months
    type: number

  imp_ret_pop:
    description: >-
      Population: OUD; nonspecific CP
    type: number

  imp_ret_inter:
    description: >-
      Intervention: PSM vs Flexible bup vs PSM + Flexible bup vs TAU
    type: number

  imp_ret_sd:
    description: >-
      Study design: 2x2 Factorial Design; Hybrid Type I
    type: number

  imp_ret_moud:
    description: >-
      MOUD: Buprenorphine/naloxone
    type: number

  imp_ret_if:
    description: >-
      Implementation framework: Health Equity Implementation Framework
    type: number

  imp_ret_econ:
    description: >-
      Economic analysis: yes
    type: number

  imp_ret_setting:
    description: >-
      Setting: office-based opioid treatment programs (OBOTs)
    type: number

  imp_ret_sample:
    description: >-
      Sample size: 458
    type: number

  imp_ret_followup:
    description: >-
      Follow-up: 0, 1, 2, 3, 6, 9, 12 months
    type: number

  imp_nm_studyname:
    description: >-
      Which study is the patient participating in?
    enum: []

  imp_hope_pop:
    description: >-
      Population: Opioid use disorder and nonspecific chronic pain
    type: number

  imp_hope_inter:
    description: >-
      Intervention: Yoga vs Physical Therapy vs Treatment as usual (TAU)
    type: number

  imp_hope_sd:
    description: >-
      Study Design: Type I
    type: number

  imp_hope_if:
    description: >-
      Implementation Framework:CFIR
    type: number

  imp_hope_econ:
    description: >-
      Economic analysis: Yes
    type: number

  imp_hope_moud:
    description: >-
      MOUD: Buprenorphine
    type: number

  imp_hope_setting:
    description: >-
      Health Setting: OTP
    type: number

  imp_hope_sample:
    description: >-
      Sample size: 45 providers/160 clients
    type: number

  imp_hope_followup:
    description: >-
      Follow-up: End of treatment, 6- and 12-months post-treatment
    type: number

  impowr_optic_pop:
    description: >-
      Population: OUD/misuse; nonspecific CP
    type: number

  impowr_optic_inter:
    description: >-
      Intervention: AI/AN culturally-adapted MI to increase screening/treatment initiation
      via academic detailing implementation strategy
    type: number

  impowr_optic_sd:
    description: >-
      Study Design: Step Wedge Clustered RCT; Type III
    type: number

  impowr_optic_if:
    description: >-
      Implementation Framework: RE-AIM & CFIR
    type: number

  impowr_optic_econ:
    description: >-
      Economic analysis: yes
    type: number

  impowr_optic_moud:
    description: >-
      MOUD: Dependent on access
    type: number

  impowr_optic_setting:
    description: >-
      Health Setting: Primary Care
    type: number

  impowr_optic_sample:
    description: >-
      Sample size: 45 providers/225 clients
    type: number

  impowr_optic_followup:
    description: >-
      Follow ups: 4-, 8- and 12-months post-baseline
    type: number

  imp_jh_studysite:
    description: >-
      The patient is enrolled in  "Randomized Clinical Trial Intervention to Treat
      Chronic Pain Among Persons Maintained on Methadone for Opioid Use Disorder
    enum: []

  imp_jh_pop:
    description: >-
      Population: OUD; nonspecific CP
    type: number

  imp_jh_inter:
    description: >-
      Intervention: Standard vs split (2x/day) methadone dosing
    type: number

  imp_jh_sd:
    description: >-
      Study design: 2 Arm RCT
    type: number

  imp_jh_if:
    description: >-
      Implementation framework: none
    type: number

  imp_jh_econ:
    description: >-
      Economic analysis: none
    type: number

  imp_jh_moud:
    description: >-
      MOUD: Methadone
    type: number

  imp_jh_setting:
    description: >-
      Setting: OTP
    type: number

  imp_jh_sample:
    description: >-
      Sample size: 150
    type: number

  imp_jh_followup:
    description: >-
      Follow-up: 6 months
    type: number

  imp_rutgers_studysite:
    description: >-
      The patient is enrolled in  "Implementation and Effectiveness of Mindfulness
      Oriented Recovery Enhancement as an Adjunct to Methadone Treatment for Opioid
      Use Disorder
    enum: []

  imp_rutgers_pop:
    description: >-
      Population: OUD; nonspecific CP
    type: number

  imp_rutgers_inter:
    description: >-
      Intervention: Mindfulness-Oriented Recovery Enhancement (MORE) vs scripted mindfulness
      practice vs TAU; implementation strategy is train the trainer vs LCSW
    type: number

  imp_rutgers_sd:
    description: >-
      Stage 2 3arm RCT
    type: number

  imp_rutgers_if:
    description: >-
      Implementation framework: RE-AIM (Hybrid Type II trial)
    type: number

  imp_rutgers_econ:
    description: >-
      Economic analysis: none
    type: number

  imp_rutgers_moud:
    description: >-
      MOUD: Methadone
    type: number

  imp_rutgers_setting:
    description: >-
      Setting: OTP
    type: number

  imp_rutgers_sample:
    description: >-
      Sample size: 420
    type: number

  imp_rutgers_followup:
    description: >-
      Follow-up: 8, 16, 24, and 52 weeks
    type: number

  projects:
    $ref: "_definitions.yaml#/to_one_project"
